Cullin-2 (CUL2) primarily based cullin-RING ligases (CRL2s) comprise a household of ubiquitin E3 ligases that exist solely in multi-cellular organisms and are essential for mobile processes equivalent to embryogenesis and viral pathogenesis. CUL2 is the scaffold protein that binds one of the interchangeable substrate receptor modules, which consists of adaptor proteins and the substrate receptor protein. The VHL protein is a substrate receptor identified to focus on hypoxia-inducible issue α (HIF1α) for ubiquitination and degradation.
Because of its essential function within the ubiquitination of necessary mobile components equivalent to HIF1α, CRL2s have been investigated for his or her organic features and the event of novel therapeutics towards illnesses. Given the significance of CRL2s in organic and biomedical analysis, strategies that effectively produce functional CUL2 proteins will significantly facilitate research on the mechanism and regulation of CRL2s.
Here, we report two cost-effective programs for the expression and purification of recombinant human CUL2 from E. coli cells. The purified CUL2 proteins have been ~ 95% pure, may bind their substrate receptor modules, and have been enzymatically lively in transferring ubiquitin or ubiquitin-like protein to the corresponding substrate in in vitro assays. The introduced methodological developments will assist advance analysis in CRL2 perform and regulation.
Milligram scale expression, refolding, and purification of Bombyx mori cocoonase utilizing a recombinant E. coli system
Silk is one of probably the most versatile biomaterials with signature properties of excellent mechanical energy and flexibility. A possible avenue for growing extra environmentally pleasant silk manufacturing is to make use of the silk moth (Bombyx mori) cocoonase, this may on the similar time improve the likelihood for utilizing the byproduct, sericin, as a uncooked materials for different functions.
Cocoonase is a serine protease utilized by the silk moth to melt the cocoon to allow its escape after accomplished metamorphosis. Cocoonase selectively degrades the glue protein of the cocoon, sericin, with out affecting the silk-fiber made of the protein fibroin. Cocoonase might be recombinantly produced in E. coli, nevertheless, it’s solely discovered as insoluble inclusion our bodies.
To clear up this drawback and to have the ability to make the most of the advantages related to an E. coli primarily based expression system, we’ve developed a protocol that allows the manufacturing of soluble and functional protease within the milligram/liter scale. The core of the protocol is refolding of the protein in a buffer with a redox potential that’s optimized for formation of native and intramolecular di-sulfide bridges.
The redox potential was balanced with outlined concentrations of decreased and oxidized glutathione. This E coli primarily based manufacturing protocol will, along with construction dedication, additionally allow modification of cocoonase each in phrases of catalytic perform and stability. These components might be helpful parts within the growth of alternate silk manufacturing methodology.
Expression of Bacillus amyloliquefaciens transglutaminase in recombinant E. coli below the management of a bicistronic plasmid system in DO-stat fed-batch bioreactor cultivations
We studied the expression of Bacillus amyloliquefaciens transglutaminase cloned in Escherichia coli BL21(DE3)pLysS harboring the plasmid pBAD/3C/bTGase, a bicistronic expression system, in bioreactor cultivation. Batch and fed-batch managed as DO-stat methods have been employed for the manufacturing of the recombinant enzyme. In 30 h-batch cultivations utilizing Terrific broth (TB), 6 g/L of biomass and 3.12 U/mgprotein of transglutaminase exercise have been obtained.
DO-stat fed-batch cultivations below the management of oxygen focus (DO-stat) utilizing TB as medium however fed with glucose allowed the increment in biomass formation (17.5 g/L) and enzyme exercise (6.43 U/mgprotein). DO-stat fed-batch utilizing mineral medium (M9) and fed with glucose below the identical situations produced even greater enzymatic exercise (9.14 U/mgprotein).
The pH impact was investigated, and one of the best enzymatic exercise may very well be noticed at pH 8. In all cultivations, the bicistronic system remained secure, with 100% of plasmid-bearing cells. These outcomes present that E. coli bearing bicistronic plasmid constructs to specific recombinant TGase may very well be cultivated in bioreactors below DO-stat fed-batch utilizing mineral medium and it’s a promising technique in future optimizations to provide this necessary enzyme.
Characterization of Recombinant E. coli Expressing a Novel Fucosidase from Bacillus cereus 2-Eight belonging to GH95 Family
Fucoidan oligosaccharides possesses numerous physicochemical and organic actions. Specific glycoside hydrolases are helpful instruments for degrading polysaccharides to provide oligosaccharides. In this examine, BcFucA, a novel fucosidase belonging to GH95 household from Bacillus cereus 2-8, was cloned into pET21a vector, expressed in E. coli BL21 (DE3) and characterised.
AIDA Antibody |
MBS7134830-01mL |
MyBiosource |
0.1mL |
EUR 270 |
AIDA Antibody |
MBS7134830-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1205 |
AIDA Antibody |
DF15062-100ul |
Affinity Biosciences |
100ul |
EUR 168 |
|
Description: IHC,IF/ICC,ELISA(peptide) |
AIDA Antibody |
DF15062-200ul |
Affinity Biosciences |
200ul |
EUR 210 |
|
Description: IHC,IF/ICC,ELISA(peptide) |
AIDA Antibody |
MBS9632733-5x1mg |
MyBiosource |
5x1mg |
EUR 1545 |
AIDA Antibody |
MBS9630350-01mL |
MyBiosource |
0.1mL |
EUR 260 |
AIDA Antibody |
MBS9630350-02mL |
MyBiosource |
0.2mL |
EUR 305 |
AIDA Antibody |
MBS9630350-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
aida Antibody |
CSB-PA761322XA01DIL-02mg |
Cusabio |
0.2mg |
Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) aida protein |
aida Antibody |
CSB-PA761322XA01DIL-10mg |
Cusabio |
10mg |
Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) aida protein |
AIDA (untagged)-Human axin interactor, dorsalization associated (AIDA) |
SC112378 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AIDA cDNA Clone |
MBS1268688-001mgPlasmid02mLGlycerolStock |
MyBiosource |
0.01mgPlasmid+0.2mLGlycerol-Stock |
EUR 200 |
AIDA cDNA Clone |
MBS1268688-5x001mgPlasmid5x02mLGlycerolStock |
MyBiosource |
5x0.01mgPlasmid+5x0.2mLGlycerol-Stock |
EUR 855 |
Mouse AIDA siRNA |
20-abx907083 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Human AIDA siRNA |
20-abx907084 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
AIDA siRNA (Human) |
MBS8227846-15nmol |
MyBiosource |
15nmol |
EUR 405 |
AIDA siRNA (Human) |
MBS8227846-30nmol |
MyBiosource |
30nmol |
EUR 565 |
AIDA siRNA (Human) |
MBS8227846-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
AIDA siRNA (Mouse) |
MBS8209465-15nmol |
MyBiosource |
15nmol |
EUR 405 |
AIDA siRNA (Mouse) |
MBS8209465-30nmol |
MyBiosource |
30nmol |
EUR 565 |
AIDA siRNA (Mouse) |
MBS8209465-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
aidA-I Antibody |
CSB-PA183385XA01ENL-02mg |
Cusabio |
0.2mg |
Ask for price |
|
Description: Recombinant Escherichia coli aidA-I protein |
aidA-I Antibody |
CSB-PA183385XA01ENL-10mg |
Cusabio |
10mg |
Ask for price |
|
Description: Recombinant Escherichia coli aidA-I protein |
anti- AIDA antibody |
FNab00234 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against AIDA |
AIDA cloning plasmid |
CSB-CL839294HU-10ug |
Cusabio |
10ug |
EUR 279.6 |
|
Description: A cloning plasmid for the AIDA gene. |
AIDA (GFP-tagged) - Human axin interactor, dorsalization associated (AIDA) |
RG217521 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Recombinant Human AIDA |
MBS7616425-005mg |
MyBiosource |
0.05mg |
EUR 470 |
Recombinant Human AIDA |
MBS7616425-02mg |
MyBiosource |
0.2mg |
EUR 885 |
Recombinant Human AIDA |
MBS7616425-1mg |
MyBiosource |
1mg |
EUR 2540 |
Recombinant Human AIDA |
MBS7616425-5x1mg |
MyBiosource |
5x1mg |
EUR 9820 |
Recombinant Human AIDA |
MBS7611060-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human AIDA |
MBS7611060-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human AIDA |
MBS7611060-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human AIDA |
MBS7611060-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
AIDA, 1-306aa, Human, His tag, E Coli |
MBS205394-0004mg |
MyBiosource |
0.004mg |
EUR 215 |
AIDA, 1-306aa, Human, His tag, E Coli |
MBS205394-002mg |
MyBiosource |
0.02mg |
EUR 340 |
AIDA, 1-306aa, Human, His tag, E Coli |
MBS205394-01mg |
MyBiosource |
0.1mg |
EUR 765 |
AIDA, 1-306aa, Human, His tag, E Coli |
MBS205394-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3195 |
Aida (Myc-DDK-tagged) - Mouse axin interactor, dorsalization associated (Aida) |
MR204280 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AIDA (Myc-DDK-tagged)-Human axin interactor, dorsalization associated (AIDA) |
RC217521 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Aida (NM_181732) Mouse Recombinant Protein |
E45M47447M5 |
EnoGene |
20 ug |
EUR 1924.54 |
AIDA protein (His tag) |
80R-2681 |
Fitzgerald |
20 ug |
EUR 329 |
|
Description: Purified recombinant AIDA protein (His tag) |
AIDA Antibody (C-term) |
E45R04233G-1 |
EnoGene |
100 ul |
EUR 395 |
AIDA Antibody (C-term) |
E45R04233G-4 |
EnoGene |
50 ul |
EUR 295 |
AIDA Antibody (C-term) |
MBS9201306-008mL |
MyBiosource |
0.08mL |
EUR 210 |
AIDA Antibody (C-term) |
MBS9201306-04mL |
MyBiosource |
0.4mL |
EUR 430 |
AIDA Antibody (C-term) |
MBS9201306-5x04mL |
MyBiosource |
5x0.4mL |
EUR 1910 |
Human AIDA shRNA Plasmid |
20-abx962119 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Mouse AIDA shRNA Plasmid |
20-abx979944 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Human AIDA Protein Lysate |
MBS137038-002mg |
MyBiosource |
0.02mg |
EUR 365 |
Human AIDA Protein Lysate |
MBS137038-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1410 |
AIDA Recombinant Rabbit mAb |
BS48755 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
AIDA Antibody, HRP Conjugated |
MBS7134831-005mL |
MyBiosource |
0.05mL |
EUR 190 |
AIDA Antibody, HRP Conjugated |
MBS7134831-01mL |
MyBiosource |
0.1mL |
EUR 270 |
AIDA Antibody, HRP Conjugated |
MBS7134831-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1205 |
AIDA Antibody, FITC Conjugated |
MBS7134832-005mL |
MyBiosource |
0.05mL |
EUR 190 |
AIDA Antibody, FITC Conjugated |
MBS7134832-01mL |
MyBiosource |
0.1mL |
EUR 270 |
AIDA Antibody, FITC Conjugated |
MBS7134832-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1205 |
Recombinant Human AIDA Protein |
E30P62280A |
EnoGene |
50 ug |
EUR 295 |
AIDA Recombinant Protein (Human) |
RP000832 |
ABM |
100 ug |
Ask for price |
AIDA Recombinant Protein (Mouse) |
RP115019 |
ABM |
100 ug |
Ask for price |
AIDA Antibody, Biotin Conjugated |
MBS7134833-005mL |
MyBiosource |
0.05mL |
EUR 190 |
AIDA Antibody, Biotin Conjugated |
MBS7134833-01mL |
MyBiosource |
0.1mL |
EUR 270 |
AIDA Antibody, Biotin Conjugated |
MBS7134833-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1205 |
AIDA Rabbit Polyclonal Antibody |
E10G31837 |
EnoGene |
100 μl |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
AIDA sgRNA CRISPR Lentivector (Human) (Target 1) |
K0062102 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Aida sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K4069402 |
ABM |
1.0 ug DNA |
EUR 184.8 |
C1orf80 (AIDA) (NM_022831) Human Recombinant Protein |
E45H35418M5 |
EnoGene |
20 ug |
EUR 785.42 |
C1orf80 (AIDA) (NM_022831) Human Recombinant Protein |
PROTQ96BJ3 |
BosterBio |
Regular: 10ug |
EUR 1249 |
Description: Recombinant protein of human axin interactor, dorsalization associated (AIDA) |
AIDA (C-term) Rabbit pAb |
E2613568 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
AIDA (C-Term) Rabbit pAb |
MBS8552977-01mL |
MyBiosource |
0.1mL |
EUR 305 |
AIDA (C-Term) Rabbit pAb |
MBS8552977-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
AIDA (C-Term) Rabbit pAb |
MBS8552977-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
AIDA (C-Term) Rabbit pAb |
MBS8552977-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
AIDA (C-Term) Rabbit pAb |
MBS8552977-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
AIDA ORF Vector (Human) (pORF) |
ORF000278 |
ABM |
1.0 ug DNA |
EUR 114 |
Aida ORF Vector (Mouse) (pORF) |
ORF038341 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Human AIDA knockout cell line |
ABC-KH0431 |
AcceGen |
1 vial |
Ask for price |
Description: Human AIDA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Lenti ORF clone of Aida (mGFP-tagged) - Mouse axin interactor, dorsalization associated (Aida) |
MR204280L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Human AIDA knockdown cell line |
ABC-KD0431 |
AcceGen |
1 vial |
Ask for price |
Description: Human AIDA knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human AIDA Protein Lysate 20ug |
IHUAIDAPLLY20UG |
Innovative research |
each |
EUR 213 |
|
Description: Human AIDA Protein Lysate 20ug |
AIDA Peptide - N-terminal region |
MBS3240768-01mg |
MyBiosource |
0.1mg |
EUR 180 |
AIDA Peptide - N-terminal region |
MBS3240768-5x01mg |
MyBiosource |
5x0.1mg |
EUR 730 |
AIDA Peptide - N-terminal region |
MBS3240769-01mg |
MyBiosource |
0.1mg |
EUR 180 |
AIDA Peptide - N-terminal region |
MBS3240769-5x01mg |
MyBiosource |
5x0.1mg |
EUR 730 |
Polyclonal AIDA Antibody (C-term) |
APR04233G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human AIDA (C-term). This antibody is tested and proven to work in the following applications: |
AIDA antibody - N-terminal region |
MBS3215866-01mL |
MyBiosource |
0.1mL |
EUR 455 |
AIDA antibody - N-terminal region |
MBS3215866-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1995 |
AIDA antibody - N-terminal region |
MBS3215867-01mL |
MyBiosource |
0.1mL |
EUR 455 |
AIDA antibody - N-terminal region |
MBS3215867-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1995 |
AIDA Over-expression Lysate Product |
GWB-956789 |
GenWay Biotech |
0.1 mg |
Ask for price |
AIDA (15O14) Rabbit Monoclonal Antibody |
E28M2577 |
EnoGene |
100ul |
EUR 295 |
C1orf80 (AIDA) (NM_022831) Human Over-expression Lysate |
LS064853 |
BosterBio |
100ug |
EUR 628 |
|
Description: Transient overexpression lysate of axin interactor, dorsalization associated (AIDA) |
C1orf80 (AIDA) (NM_022831) Human Over-expression Lysate |
E45H11793-2 |
EnoGene |
each |
EUR 395 |
Lenti ORF clone of Aida (Myc-DDK-tagged) - Mouse axin interactor, dorsalization associated (Aida) |
MR204280L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF particles, Aida (GFP-tagged) - Mouse axin interactor, dorsalization associated (Aida), 200ul, >10^7 TU/mL |
MR204280L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, AIDA (mGFP-tagged) - Human axin interactor, dorsalization associated (AIDA), 200ul, >10^7 TU/mL |
RC217521L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
AIDA sgRNA CRISPR Lentivector set (Human) |
K0062101 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Aida sgRNA CRISPR Lentivector set (Mouse) |
K4069401 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
AIDA Antibody (C-term) Blocking Peptide |
MBS9222737-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Lenti ORF particles, Aida (Myc-DDK-tagged) - Mouse axin interactor, dorsalization associated (Aida), 200ul, >10^7 TU/mL |
MR204280L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, AIDA (Myc-DDK tagged) - Human axin interactor, dorsalization associated (AIDA), 200ul, >10^7 TU/mL |
RC217521L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
AIDA 3'UTR GFP Stable Cell Line |
TU050511 |
ABM |
1.0 ml |
EUR 1825.2 |
Aida 3'UTR GFP Stable Cell Line |
TU151582 |
ABM |
1.0 ml |
Ask for price |
AIDA, CT (AIDA, C1orf80, Axin interactor, dorsalization-associated protein, Axin interaction partner and dorsalization antagonist) |
MBS6009442-02mL |
MyBiosource |
0.2(mL |
EUR 695 |
AIDA, CT (AIDA, C1orf80, Axin interactor, dorsalization-associated protein, Axin interaction partner and dorsalization antagonist) |
MBS6009442-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2975 |
AIDA Protein Vector (Human) (pPM-C-HA) |
PV001111 |
ABM |
500 ng |
EUR 394.8 |
AIDA Protein Vector (Mouse) (pPM-C-HA) |
PV153364 |
ABM |
500 ng |
EUR 723.6 |
AIDA Protein Vector (Human) (pPB-C-His) |
PV001109 |
ABM |
500 ng |
EUR 394.8 |
AIDA Protein Vector (Human) (pPB-N-His) |
PV001110 |
ABM |
500 ng |
EUR 394.8 |
AIDA Protein Vector (Human) (pPM-C-His) |
PV001112 |
ABM |
500 ng |
EUR 394.8 |
The protein consists of 1136 amino acid residues encoded by 3411 bases and has a molecular weight of 125.35 kDa. The optimum temperature and pH of this enzyme are 50°C and pH 4.0. In addition, this examine confirmed that the unknown perform area (encoding Lys261-Thr681) outlined as a linker is sort of necessary for its exercise. The obtained novel enzyme BcFucA will contribute to the efficient degradation of fucoidan and future industrial functions.